Federal Research & Development in Biotechnology… contracting in Maryland.
Federal agencies obligated $182.2M on Research and Development in Biotechnology (except Nanobiotechnology) (NAICS 541714) performed in Maryland in FY2024 — the #27 largest federal contracting category in the state, roughly 4.7% of all U.S. federal spend in this NAICS.
How a Maryland firm wins Research & Development in Biotechnology… work
Register on SAM.gov
An active SAM registration under NAICS 541714 is the gate. P4 One LLC is SAM-active (UEI SW9VDGLV8AY6).
Target the buyers
See which federal agencies buy this work and respond to their solicitations on SAM.gov.
Respond sharp
A clear capability statement and relevant past performance win the shortlist.
Source: USAspending.gov — federal prime-contract awarding-agency obligations, FY2024 (public record). Figures are historical award totals shown for buyer research, not a forecast, guarantee, or solicitation. Verify current opportunities and eligibility at SAM.gov and the issuing agency.